AbbVie UK


Research-driven pharmaceutical company focused on discovery and development across oncology, immunology, neuroscience, eye care and medical aesthetics. Operates R&D, clinical development, regulatory and manufacturing functions in the UK, partners with health systems and academic institutions, and applies genomics, biomarker science and AI-driven analytics across drug development.

Industries

Biopharma
Biotechnology
Clinical Trials
Communities
Education
Financial Services
Genetics
Health Care
Health Diagnostics
Manufacturing
Medical
Medical Device
Personalization
Pharmaceutical
Precision Medicine
Therapeutics
Venture Capital
Pharmaceutical Manufacturing

Nr. of Employees

medium (51-250)

AbbVie UK


Services

Arm's-length grants to eligible healthcare organisations for scientific, educational and quality-of-care projects aligned to medical strategies.

Support for investigator-initiated studies and collaboration with clinical trial sites, including site network engagement and patient recruitment.

Expertise Areas

  • Clinical trial management and site operations
  • Regulatory compliance, pharmacovigilance and transparency reporting
  • Drug discovery and translational research
  • Therapeutic modality development (antibodies, ADCs, targeted degradation, gene and cell therapies)
  • Show More (8)

Key Technologies

  • Genomics and high-throughput sequencing
  • Molecular profiling and biomarker assays
  • AI and machine learning
  • Biostatistics and advanced analytics
  • Show More (6)

News & Updates

Article describing employee development initiatives and recognition among the UK's Best Workplaces for Development 2026.

Article about an employee resource group promoting wellbeing activities including Run Club, onsite gym access, yoga and Pilates.

Recognised as a Great Place to Work for 12 consecutive years.

Named among the UK's Best Workplaces for Development 2026.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.